Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Frontiers in Oncology|November 17, 2022
TMEM158 expression is negatively regulated by AR signaling and associated with favorite survival outcomes in prostate cancersJian Huang, Wang Liu, Da Zhang, et al.
Frontiers in Pharmacology|July 9, 2026
Alternol inhibits GAPDH activity and disrupts glycolytic flux preferentially in cancer cellsYuelong Chai, Wang Liu, Moben Mirza, et al.
Molecular Pharmaceutics|April 23, 2011
Development of a peptide-drug conjugate for prostate cancer therapyWanyi Tai, Ravi S Shukla, Bin Qin, et al.
Molecular Cancer Therapeutics|November 18, 2003
Glycogen synthase kinase-3beta suppression eliminates tumor necrosis factor-related apoptosis-inducing ligand resistance in prostate cancerXinbo Liao, Liping Zhang, J Brantley Thrasher, et al.
Endocrinology|February 28, 2004
Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancerXinbo Liao, J Brantley Thrasher, Jeffery Holzbeierlein, et al.
Frontiers in Medicine|May 15, 2025
Renal oncocytoma with liver metastasis: a case report with genetic analysis and literature reviewIssa Al-Kharouf, Carmen Miller, Ameer Hamza, et al.
American Journal of Clinical and Experimental Urology|November 7, 2014
PI-3 kinase p110β: a therapeutic target in advanced prostate cancersBenyi Li, Aijing Sun, Wencong Jiang, et al.
Molecular Cancer Therapeutics|April 14, 2005
Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancerXinbo Liao, Siqing Tang, J Brantley Thrasher, et al.
Diabetes Care|April 7, 2010
Association of testosterone and sex hormone-binding globulin with metabolic syndrome and insulin resistance in menChaoyang Li, Earl S Ford, Benyi Li, et al.
Bladder (San Francisco, Calif.)|August 1, 2025
Expression profiles and clinical significance of cystatin family genes in transitional cell carcinoma of the urinary bladderHaixia Xu, Wang Liu, Xiangxing Kuang, et al.
Pageof 8